Michael Savin, MD, Oncology, Portland, OR

MichaelAlanSavinMD

Oncology Portland, OR

Hematologic Oncology

Physician

Dr. Savin is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Savin's full profile

Already have an account?

  • Office

    Knight Cancer Institute, Oregon Health & Science University
    3181 SW Sam Jackson Park Rd
    Portland, OR 97239
    Phone(503) 494-5672
    Fax(503) 494-4285
  • Is this information wrong?

Education & Training

  • U Washington Affil HospsFellowship, Hematology and Oncology (IM), 1975
  • Duke University Hospital
    Duke University HospitalResidency, Internal Medicine, 1973
  • Duke University Hospital
    Duke University HospitalInternship, Internal Medicine, 1969 - 1970
  • University of Pittsburgh School of Medicine
    University of Pittsburgh School of MedicineClass of 1969
  • Harvard UniversityA.B., History and Science, Cum Laude, 1965

Certifications & Licensure

  • MO State Medical License
    MO State Medical License 2020 - 2022
  • OR State Medical License
    OR State Medical License 2014 - 2021
  • TX State Medical License
    TX State Medical License 1987 - 2021
  • NY State Medical License
    NY State Medical License 1978 - 2021
  • CA State Medical License
    CA State Medical License 1975 - 2022
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • US Oncology Research Honor for Enrolling Over 100 Patients 14th Annual Science Forum, 2015
  • Regional Top Doctor Castle Connolly, 2014
  • Oncology Top Doctors by Sally Giddens The Magazine of Dallas, 1992
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Quantitative measurement of HER2 expression in breast cancers: comparison with ‘real-world’ routine HER2 testing in a multicenter Collaborative Biomarker...  
    Yardley DA, Kaufman PA, Huang W, Krekow L, Savin MA, Lawler WE, Zrada S, Starr A, Einhorn H, Schwartzberg LS, Adams JW, Lie Y, Paquet AC, Sperinde J,..., Breast Cancer Research, 1/1/2015
  • A Phase II Study of Eribulin Mesylate (E7389) in Patients With Advanced, Previously-Treated Non-Small Cell Lung Cancer  
    Spira AI, Iannotti NO, Savin MA, Neubauer M, Gabrail NY, Yanagihara RH, Zang EA, Cole PE, Shuster D, Das A, Clinical Lung Cancer, 1/1/2012
  • Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7- Year Follow-Up of US Oncology Researc...  
    Jones S, Holmes FA, O’Shaughnessy J, Blum JL, Vukelja SJ, McIntyre KJ, Pippen JE, Bordelon JH, Kirby RL, Sandbach J, Hyman WJ, Richards DA, Mennel RG, Boehm KA, Meyer ..., Journal of Clinical Oncology, 1/1/2009
  • Join now to see all

Books/Book Chapters

Abstracts/Posters

  • Scalp Cooling Alopecia Prevention Trial (SCALP) for Patients with Early Stage Breast Cancer
    Nangia JR, Wang, T Rude, M Osborne, C Papish, M Abraham, J, Holmes F, Savin M, Paxman R, Hilsenbeck SG, Osborne K, Rimawi MF, ASCO 2016 Annual Meeting, 1/1/2016
  • Abstract OT3-02-08: Scalp cooling alopecia prevention trial (SCALP) for patients with early stage breast cancer
    Nangia JR, Wang T, Rude M, Osborne C, Papish M, Abraham J, Holmes F, Savin M, Paxman R, Hilsenbeck SG, Osborne K, Rimawi MF, Ongoing Trials-Chemotherapy, San Antonio Breast Cancer Symposium, 1/1/2015
  • CD30 expression in nonlymphomatous malignancies
    Sharman, J.P., Goldschmidt, J.H., Burke, J.M., Hellerstedt, B.A., McIntyre, K., Yasenchak, C.A., Boyd, T.E., Ruxer, R.L., Patel- Donnelly, D., Braiteh, F.S., Fo..., Annual meeting, American Society of Clinical Oncology, 1/1/2012
  • Join now to see all

Press Mentions

  • Dr. Michael Savin, M.D., Has Been Recognized as One of America's Most Influential Physicians by the International Association of Who's Who
    Dr. Michael Savin, M.D., Has Been Recognized as One of America's Most Influential Physicians by the International Association of Who's WhoNovember 15th, 2019
  • The Leading Physicians of the World Will Be Displaying Distinguished Hematologist and Oncologist, Michael A. Savin, MD
    The Leading Physicians of the World Will Be Displaying Distinguished Hematologist and Oncologist, Michael A. Savin, MDSeptember 27th, 2017
  • Venerated Oncologist Michael A. Savin, MD, Will Be Highlighted in the Leading Physicians of the World
    Venerated Oncologist Michael A. Savin, MD, Will Be Highlighted in the Leading Physicians of the WorldOctober 6th, 2016

Other Languages

  • Spanish, German